Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06096441 · ClinicalTrials.gov registry record
FSHD Molecular Characterization
A clinical trial, sponsored by Nationwide Children's Hospital.
- Terminated
- Registry status
- 1
- Enrollment target
NCT06096441: Clinical Trial study, sponsored by Nationwide Children's Hospital.
NCT06096441 is a clinical trial that was terminated before completion, run by Nationwide Children's Hospital. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06096441 was terminated before completion, sponsored by Nationwide Children's Hospital.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
To characterize the clinical and molecular phenotype of FSHD.
Primary Outcome
To validate alterations in therapeutically relevant biomarkers in muscle tissue from FSHD participants. Each participant will provide data at a single timepoint. The data in totality will be reviewed upon study completion.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2021-03-05 |
| Est. Completion | 2025-09-09 |
Why NCT06096441 stopped before completion
NCT06096441 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT06096441 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06096441 about?
NCT06096441 is a clinical study titled "FSHD Molecular Characterization". To characterize the clinical and molecular phenotype of FSHD.
What is the current status of trial NCT06096441?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2021-03-05. Estimated completion is 2025-09-09.
Who is sponsoring clinical trial NCT06096441?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI